
Quince Therapeutics Investor Relations Material
Latest events

Investor Update
Quince Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Quince Therapeutics Inc
Access all reports
Quince Therapeutics Inc is a U.S.-based biopharmaceutical company focused on the development and commercialization of targeted therapeutics for debilitating and rare diseases. The company’s pipeline includes treatments designed to improve drug delivery and tissue targeting for enhanced efficacy and safety. Quince Therapeutics leverages proprietary platforms and collaborates with partners to advance its clinical and preclinical programs. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Quince Therapeutics Inc


The ThinkEquity Conference 2024
Quince Therapeutics Inc


Investor Presentation
Quince Therapeutics Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
QNCX
Country
🇺🇸 United States